文献速递泌尿系结石

基线尿钙与噻嗪类利尿剂预防肾结石的疗效

Baseline Urinary Calcium and the Efficacy of Thiazide Diuretics for Kidney Stone Prevention.
PubMed 文献 · J Urol · 2026-03-27

该研究纳入634例新处方噻嗪类利尿剂的肾结石患者,分析基线24小时尿钙与尿钙变化及结石事件的关系。结果显示基线尿钙越高,尿钙绝对和百分比下降越大(Ptrend<0.001),噻嗪剂量越高下降越大,但治疗后结石事件发生率在各基线尿钙组间无显著差异;未用药者基线尿钙越高结石事件累积发生率越高。

要点

  • 基线尿钙越高,噻嗪类利尿剂降低尿钙的幅度越大。
  • 噻嗪剂量越高,尿钙绝对和百分比下降越大。
  • 治疗后结石事件在各基线尿钙组间无显著差异。

核心结论

  • 基线尿钙较高的患者使用噻嗪类利尿剂后尿钙下降更明显,且剂量越高下降越大。

研究设计与样本

  • 回顾性队列研究,纳入2011至2018年Labcorp/Litholink处理的24小时尿液收集的Medicare受益人,筛选年龄>18岁、新处方噻嗪类利尿剂且在初始处方后30至180天完成第二次尿液收集者,共634例。

主要发现

  • 基线尿钙越高,24小时平均绝对尿钙下降(mg/d)和百分比下降越大(Ptrend<0.001)。
  • 噻嗪剂量越高,尿钙绝对和百分比下降越大。
  • 噻嗪处方后,各基线尿钙组间临床结石事件调整后累积发生率无统计学显著差异。
  • 未暴露于噻嗪者中,基线尿钙越高,未调整和调整后累积结石事件发生率越高(Ptrend<0.001)。

临床怎么用

  • 可根据基线尿钙水平个体化调整噻嗪类利尿剂剂量以预防肾结石。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: Previous studies have shown that thiazide diuretics' ability to decrease symptomatic stone events depends on the extent to which they reduce urine calcium. However, it remains unknown whether the calcium change from thiazide diuretics depends on the baseline urine calcium level. MATERIALS AND METHODS: Among a cohort of Medicare beneficiaries with a 24-hour urine collection for kidney stone disease processed by Labcorp/Litholink between 2011 and 2018, we identified a subset aged > 18 years newly prescribed a thiazide diuretic who performed a second collection between 30 and 180 days after their initial prescription fill. We then fit multivariable linear regression models to estimate the association between dose of thiazide prescribed and change in urine calcium, stratifying by baseline urine calcium. We compared cumulative incidences of clinical stone events stratified by baseline urine calcium groups within a treated and untreated cohort. RESULTS: From a total of 634 participants, higher baseline urine calcium was associated with greater 24-hour mean absolute (in mg/d) and percentage urine calcium reductions (Ptrend < 0.001 for both). Higher thiazide dose was associated with greater absolute and percentage urine calcium reduction. No statistically significant differences were seen comparing the adjusted incidences of clinical stone events across baseline calcium groups after thiazide prescription. However, among individuals without thiazide exposure, the unadjusted and adjusted cumulative incidences were higher with greater baseline urine calcium (both Ptrend < 0.001). CONCLUSIONS: Greater urine calcium reductions after thiazide treatment are observed among those with higher baseline urine calcium, and higher thiazide dose led to a larger reduction. These data are relevant for individualizing thiazide dose for kidney stone prevention.

来源:J Urol,查看原文。版权归原作者所有。

引用

  1. Hsi RS, Yan PL, Crivelli JJ, et al. Baseline Urinary Calcium and the Efficacy of Thiazide Diuretics for Kidney Stone Prevention. J Urol. 2026. PMID: 41894644. doi:10.1097/JU.0000000000005042

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。